Public tenders in Germany

945 open tenders

CountryTenderValueClosesDays left

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Pimecrolimus, ATC D11AH02 for the period 01.05.26 - 30.04.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 179102-2026

€11 lot, 2 years

Mon 5 Mar12:00 in Berlin

858days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Dalbavancin, ATC J01XA04 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264337-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Mesalazine (excluding Dafo RSU + KLI), ATC A07EC02 for the period 01.06.26 - 31.05.28 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 265020-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Clobazam (excluding Dafo TAB), ATC N05BA09 for the period 01.06.2026 - 31.05.2028 (including V.-option 1x12 months)

DAK-Gesundheit, HamburgTED 265426-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Clobazam (excluding Dafo SUE), ATC N05BA09 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 262578-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Gentamicin, ATC S01AA11 for the period 01.06.2026 - 31.05.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 263899-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Ganirelix, ATC H01CC01 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264661-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tianeptine, ATC N06AX14 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 263478-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Pomalidomid, ATC L04AX06 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 262873-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Mesalazine (excluding Dafo TMR), ATC A07EC02 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264504-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Methylprednisolone, ATC D07AC14 for the period 01.06.2026 - 31.05.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264128-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Fondaparinux, ATC B01AX05 for the period 01.06.2026 - 31.05.2028 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264192-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the medicinal product Bimatoprost (excluding strength 0,1 mg/ml), ATC S01EE03 for the period 01.6.26-31.5.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 263531-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Bexaroten, ATC L01XF03 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 262483-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Piperacillin + Tazobactam, ATC J01CR05 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 264726-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active substance Teduglutide, ATC A16AX08 for the period 01.06.2026 - 31.05.2028 (including extension option 1x12 months)

DAK-Gesundheit, HamburgTED 265563-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Prednicarbat, ATC D07AC18, for the period 01.06.2026 – 31.05.2028 (plus extension option 1 × 12 months)

DAK-Gesundheit, HamburgTED 262325-2026

€11 lot, 2 years

Thu 5 Apr12:00 in Berlin

889days

Conclusion of a non-exclusive discount agreement under § 130a Abs. 8 SGB V for the active ingredient Octreotid (excluding Dafo., DFL, PLS, TRS), ATC H01CB02 as of 1.7.26-30.6.28 (including V.-Option 1x12 Mon)

DAK-Gesundheit, HamburgTED 332997-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 SGB V for the active substances Calcium Carbonate + Colecalciferol, + Risedronic Acid, ATC M05BB04, for the period 01.07.26 – 30.06.28 (plus extension option 1x12 months)

DAK-Gesundheit, HamburgTED 381461-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Tolvaptan (excluding strength 7,5mg in standard size N2), valid from 01.7.26 - 30.6.28 (including V.-option 1x12 M)

DAK-Gesundheit, HamburgTED 333220-2026

€11 lot, 2 years

Sat 5 May12:00 in Berlin

919days

SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.